Acg Pharma Technologies Private Limited

Acg Pharma Technologies Private Limited - machinery and equipment in Mumbai, Maharashtra, India. Directors, charges & compliance details.
CIN U29251MH1996PTC104558 Incorporated 17 December 1996 ROC Mumbai HQ Mumbai, Maharashtra, India
Merged Private Limited Company machinery and equipment
Data last updated
Revenue · FY 2023
₹198.92 Cr
▼ 25% YoY
Net loss · FY 2023
₹41.2 Cr
Net margin -20.7%
EBITDA · FY 2023
-₹34.06 Cr
EBITDA margin -17.1%
Authorised capital
₹126.2 Cr
Registered with MCA
Paid-up capital
₹122.29 Cr
Issued & subscribed
Satisfied charges
₹2.63 Cr
No open charges
Company age
30 yrs
Est. 1996
Employees · EPFO
348
Provident fund records

About Acg Pharma Technologies Private Limited

Data last updated:

Acg Pharma Technologies Private Limited was a private limited company based in Mumbai, Maharashtra, India. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the process machinery and industrial equipment segment of the machinery and industrial equipment sector. It was incorporated on 17 December 1996.

The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U29251MH1996PTC104558. The company has 1 GST registration on record, which is no longer active.

The company had an authorised share capital of ₹126.2 Cr and a paid-up capital of ₹122.29 Cr. It was formerly known as Pam-Glatt Pharma Technologies Limited and Pam-Glatt Pharma Technologies Private Limited. It was led by directors including Shaju Kunjuvareed Thommana (Whole-Time Director) and Karan Jasjit Singh.

Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office was at 1001 Dalamal House 10th Floor Nariman Po, Mumbai, Maharashtra, India – 400021.

As per the financials filed for FY 2023, the company reported a revenue of ₹198.92 Cr, a decline of 25% compared to the previous year. For the same year it recorded a net loss of ₹41.2 Cr (net margin -20.7%) and EBITDA of -₹34.06 Cr (EBITDA margin -17.1%). Revenue has declined at a compounded annual rate (CAGR) of 2% over three years and 5% over five years.

The company had about 348 employees on its provident fund (EPFO) records before it was dissolved.

As per MCA filings, the company had satisfied charges of ₹2.63 Cr on record. Court records list 12 cases involving the company, including 7 filed by the company and 2 filed against it; 3 cases are pending. The company has 6 deals on record (4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹146.11 Cr; the latest was in June 2018. Its 10 peer companies in the Machinery and Equipment industry (Process Machinery) are compared by revenue, 5 larger and 5 smaller; the largest is Micromatic Grinding Technologies Private Limited with revenue of ₹210.98 Cr. The company has 14 MSME Form 1 returns on record between 2019 and 2023, listing 331 overdue payments to 53 micro and small suppliers.

The last known website on record is acg-world.com.

Company Details of Acg Pharma Technologies Private Limited
CIN U29251MH1996PTC104558
Registration Number 104558
Incorporation Date 17 December 1996
ROC Mumbai
Listing Status Unlisted
Company Status Amalgamated
Date of Last AGM 30 September 2023
Date of Balance Sheet 31 March 2023
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
  • Registered Address
    1001 Dalamal House 10th Floor Nariman Po, Mumbai, Maharashtra, India – 400021
  • Industry
    Machinery and Equipment, Process Machinery & Industrial Equipment
Comprehensive company report
Acg Pharma Technologies Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Acg Pharma Technologies Private Limited report

Financials, compliance, directors, charges, ownership and filings for Acg Pharma Technologies Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of Acg Pharma Technologies Private Limited

The main business activity of Acg Pharma Technologies is manufacturing. In detail, this covers electrical equipment, general purpose and special purpose machinery & equipment, transport equipment.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
CManufacturingC10Electrical equipment, General Purpose and Special purpose Machinery & equipment, Transport equipmentLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Acg Pharma Technologies Private Limited FY 2023 filings available

Acg Pharma Technologies Private Limited reported revenue of ₹198.92 Cr (down 25% YoY) for FY 2023.

Revenue · FY 2023
₹198.92 Cr ▼ 25%
Net loss · FY 2023
₹41.2 Cr margin -20.7%
EBITDA · FY 2023
-₹34.06 Cr margin -17.1%

Compounded Annual Growth Rate (CAGR) of Acg Pharma Technologies Private Limited

Revenue CAGR growth
1 year
▼ 25%
3 years · compounded
▼ 2%
5 years · compounded
▼ 5%
EBITDA CAGR growth
1 year
▼ 367%
3 years · compounded
▼ 141%
5 years · compounded
▼ 31%

Revenue has declined at a compounded annual rate (CAGR) of 5% over five years, including a 25% fall in the latest year. EBITDA fell 367% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Acg Pharma Technologies Private Limited

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA-₹34.06 Cr••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)-₹41.2 Cr••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Acg Pharma Technologies Private Limited

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profitability
EBITDA Margin-17.1%••••••••••••••••
Net Profit Margin-20.7%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Acg Pharma Technologies are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Acg Pharma Technologies Private Limited

Acg Pharma Technologies Private Limited is compared with the companies closest to it by revenue in the Machinery and Equipment industry (Process Machinery). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Micromatic Grinding Technologies Private Limited₹210.98 Cr (FY 2025)••••••••13.0%••••Ghaziabad, Uttar Pradesh, India
Vandewiele-Savio India Private Limited₹207.61 Cr (FY 2022)••••••••25.0%••••Coimbatore, Tamil Nadu, India
Nu-Vu Conair Private Limited₹207.51 Cr (FY 2025)••••••••16.0%••••Ahmedabad, Gujarat, India
Beyond Drilling and Exploration Private Limited₹206.01 Cr (FY 2025)••••••••450.0%••••Delhi, India
Parle Global Technologies Private Limited₹200.82 Cr (FY 2025)••••••••26.0%••••Vasai, Maharashtra, India
Acg Pharma Technologies Private Limited this company₹198.92 Cr (FY 2023)••••••••-25.0%••••Mumbai, Maharashtra, India
HRS Process Systems Limited₹194.39 Cr (FY 2025)••••••••-32.0%••••Pune, Maharashtra, India
SKF Elixer India Private Limited₹194.26 Cr (FY 2025)••••••••33.0%••••Mangalore, Karnataka, India
Oerlikon Textile India Private Limited₹189.77 Cr (FY 2025)••••••••8.0%••••Mumbai, Maharashtra, India
Kanchan Metals Pvt Ltd₹188.97 Cr (FY 2025)••••••••12.0%••••Kolkata, West Bengal, India
Lakshmi Card Clothing Mfg. Company Private Limited₹187.64 Cr (FY 2025)••••••••1.0%••••Coimbatore, Tamil Nadu, India

Peers are the five companies nearest above and the five nearest below Acg Pharma Technologies by revenue in the Machinery and Equipment industry (Process Machinery), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Acg Pharma Technologies Private Limited

Acg Pharma Technologies Private Limited is audited by CNK & Associates LLP for the financial year 2023.

NameStatusAppointment DateCessation Date
CNK & Associates LLPLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Acg Pharma Technologies Private Limited

Acg Pharma Technologies has 4 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.

Directors (as last reported)
NameDesignationAppointment DateTenureStatus
Karan Jasjit SinghDirector01 Apr 201313 Years 6 MonthsAs last reported
Jasjit Daljit SinghDirector17 Dec 199629 Years 9 MonthsAs last reported
Shaju Kunjuvareed ThommanaWhole-Time Director16 Oct 20196 Years 11 MonthsAs last reported
Ajit Daljit SinghDirector17 Dec 199629 Years 9 MonthsAs last reported

Ownership and Shareholding of Acg Pharma Technologies Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Acg Pharma Technologies Private Limited

Open charges
None
Satisfied charges
₹2.63 Cr
Breakdown by lending institutions
Axis Bank Limited₹2.50 Cr
State Bank of India₹0.13 Cr
Latest charge details
DateLenderAmountStatus
09 Mar 2007Axis Bank Limited₹2.5 CrSatisfied
14 Aug 2000State Bank of India₹12.5 LakhSatisfied

Total charge records: 2 View all charges

Deals & Funding of Acg Pharma Technologies Private Limited

Acg Pharma Technologies Private Limited has 6 deals on record (4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹146.11 Cr; the latest was in June 2018.

Total deals
6
Secondary share transfers
4
Funding rounds
2
Disclosed funding
₹146.11 Cr

Deals on record (5 of 6)

WhenDealAmountParties
Mar 2018Secondary share transferUndisclosedBuyer: an individual
Seller: 2 individuals
Mar 2013Secondary share transferUndisclosedBuyer: Pam Indtech Machines Private Limited
Seller: Glatt GmbH
Nov 2010Funding round₹25 CrInvestors: Pam Indtech Machines Private Limited , Acg Arts and Properties Private Limited , 2 individuals
Feb 2010Secondary share transferUndisclosedBuyer: Pam Indtech Machines Private Limited
Seller: Acg Pam Pharma Technologies Private Limited , Acg Associated Capsules Private Limited
Mar 2007Secondary share transferUndisclosedBuyer: Acg Arts and Properties Private Limited
Seller: Acg Arts and Properties Private Limited
Premium access

Full deal history

All 6 deals with amounts, valuations, instruments and every party are in the company report.

  • Every funding round and share transfer
  • Amounts and valuations
  • Investors, buyers and sellers
  • Instruments and deal dates

Verified entity values are shown only after access is granted.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME Payment Delays by Acg Pharma Technologies Private Limited

Acg Pharma Technologies Private Limited has 14 MSME Form 1 returns on record between 2019 and 2023, listing 331 overdue payments to 53 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 53)

SupplierAmount dueDue sinceReported on
Prathmesh Engineers••••••••••••
Bargain Technologies••••••••••••
Orbittal Electromech Engineering Projects Private Limited••••••••••••
an individual supplier••••••••••••
Aventics India Private Limited••••••••••••
Premium access

Full MSME payment history

Every supplier, amount and due date from all 14 MSME Form 1 returns is in the company report.

  • Every reported supplier due
  • Amounts and due dates
  • Reasons given in each return
  • Period-by-period history

Verified entity values are shown only after access is granted.

Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.

Employees and EPFO Compliance at Acg Pharma Technologies Private Limited

Acg Pharma Technologies Private Limited has a workforce of 348 employees as of Mar 22, 2024.

Employee count
348
Active EPFO establishments
1
Employee growth
-6.2%
Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Name History of Acg Pharma Technologies Private Limited

Acg Pharma Technologies has undergone 2 name changes throughout its history. The company was previously known as Pam-Glatt Pharma Technologies Limited, and Pam-Glatt Pharma Technologies Private Limited. The current legal name is Acg Pharma Technologies Private Limited.

Company NameStatus
Acg Pharma Technologies Private LimitedCurrent
Pam-Glatt Pharma Technologies LimitedPrevious
Pam-Glatt Pharma Technologies Private LimitedPrevious

News related to Acg Pharma Technologies Private Limited

Recent Activity on Acg Pharma Technologies Private Limited

Acg Pharma Technologies Private Limited has 10 board changes on record since 1996: 4 appointments and 6 cessations. The latest: Shaju Kunjuvareed Thommana ceased to be Director on 30 Oct 2019.

AGM
Acg Pharma Technologies Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Filing
Acg Pharma Technologies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.
Ceased
Shaju Kunjuvareed Thommana ceased to be Director.
Appointed
Shaju Kunjuvareed Thommana was appointed as Whole-Time Director.
Ceased
Sanjeev Kumar Dhiman ceased to be Company Secretary.
Ceased
Jagmohanlal Chopra ceased to be Director.
Ceased
Rajesh Ramanunni Menon ceased to be Director.
Ceased
Shirish Dhande ceased to be Whole-Time Director.
Charges
A charge registered on 09 Mar 2007 via Charge ID 10114672 with Axis Bank Limited was fully satisfied on 02 Jul 2015.
Ceased
Karan Jasjit Singh ceased to be Additional Director.
Appointed
Karan Jasjit Singh was appointed as Director.
Charges
A charge with Axis Bank Limited of Rs. 2.50 Cr registered on 09 Mar 2007 with Charge ID 10114672 was modified on 03 Sep 2010.

7 earlier events are listed in the company report.

Credit Ratings, Litigation & Regulatory Alerts for Acg Pharma Technologies Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Acg Pharma Technologies Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Acg Pharma Technologies Private Limited

Acg Pharma Technologies has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.

Total GSTINs
1
Cancelled / inactive
1
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Acg Pharma Technologies Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Acg Pharma Technologies Private Limited

Acg Pharma Technologies has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.

Acg Pharma Technologies was a private limited company based in Mumbai, Maharashtra, India. The company worked in process machinery and industrial equipment, within the machinery and equipment industry. It was incorporated on 17 December 1996 and is registered under CIN U29251MH1996PTC104558. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.

Acg Pharma Technologies was incorporated on 17 December 1996. It is registered with the Registrar of Companies, Mumbai.

Acg Pharma Technologies had 4 directors:

The CIN (Corporate Identification Number) of Acg Pharma Technologies is U29251MH1996PTC104558. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

The registered office of Acg Pharma Technologies is at 1001 Dalamal House 10th Floor Nariman Po, Mumbai, Maharashtra, India – 400021.

Acg Pharma Technologies can be reached through the website acg-world.com. Its registered office is in Mumbai, Maharashtra, India.

Acg Pharma Technologies reported revenue of ₹198.92 Cr for FY 2023 (down 25% YoY).

Acg Pharma Technologies has an authorised share capital of ₹126.2 Cr and a paid-up capital of ₹122.29 Cr.

Acg Pharma Technologies reported a net loss of ₹41.2 Cr (net margin -20.7%) and EBITDA of -₹34.06 Cr (EBITDA margin -17.1%) for FY 2023, as per its filed financial statements.

No. Acg Pharma Technologies has 1 GST registration on record and it is cancelled or inactive.

Acg Pharma Technologies operated in the machinery and equipment industry, in the process machinery and industrial equipment segment.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available